BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19390303)

  • 1. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.
    Markman M
    Cancer J; 2009; 15(2):105-9. PubMed ID: 19390303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
    Markman M; Reichman B; Hakes T; Rubin S; Lewis JL; Jones W; Barakat R; Curtin J; Almadrones L; Hoskins W
    Gynecol Oncol; 1993 Jul; 50(1):100-4. PubMed ID: 8349150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
    Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer.
    Zeimet AG; Reimer D; Radl AC; Reinthaller A; Schauer C; Petru E; Concin N; Braun S; Marth C
    Anticancer Res; 2009 Jul; 29(7):2803-8. PubMed ID: 19596965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP; Manahan KJ; Wiemann MC
    Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey.
    Grosso G; Rossetti D; Coccolini F; Bogani G; Ansaloni L; Frigerio L
    Arch Gynecol Obstet; 2014 Sep; 290(3):425-34. PubMed ID: 24845970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intraperitoneal chemotherapy in ovarian cancer.
    Markman M
    Clin Adv Hematol Oncol; 2006 Nov; 4(11):809-10. PubMed ID: 17143249
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer.
    Markman M
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):17-9; quiz 20, 58. PubMed ID: 8202717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies.
    Markman M
    Trends Pharmacol Sci; 2008 Oct; 29(10):515-9. PubMed ID: 18760845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?
    Markman M
    Oncology (Williston Park); 2001 Jan; 15(1):93-8; discussion 103-5. PubMed ID: 11271985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of hemoglobin levels before and during carboplatin/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer.
    Eichbaum MH; Weiss LM; Bruckner T; Schneeweiss A; Sinn HP; Gebauer G; Fersis N; Kussmaul J; Sohn C
    Med Sci Monit; 2009 Apr; 15(4):CR156-63. PubMed ID: 19333199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
    Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
    Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
    [No Abstract]   [Full Text] [Related]  

  • 14. ACOG Committee Opinion No. 396. Intraperitoneal chemotherapy for ovarian cancer.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2008 Jan; 111(1):249. PubMed ID: 18165421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal chemotherapy in ovarian cancer: an update.
    Runowicz CD
    Cancer J; 2008; 14(1):7-9. PubMed ID: 18303475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of intraperitoneal chemotherapy in the front-line setting.
    Markman M
    J Clin Oncol; 2003 May; 21(10 Suppl):145s-148s. PubMed ID: 12743130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal chemotherapy for women with epithelial ovarian cancer.
    Trimble EL; Thompson S; Christian MC; Minasian L
    Oncologist; 2008 Apr; 13(4):403-9. PubMed ID: 18448554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of intraperitoneal chemotherapy in advanced epithelial ovarian cancer.
    Maheshwari A; Gupta S; Prabhash K; Tongaonkar HB
    Indian J Cancer; 2010; 47(2):225-6. PubMed ID: 20448394
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment.
    Markman M; Walker JL
    J Clin Oncol; 2006 Feb; 24(6):988-94. PubMed ID: 16461779
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status of intraperitoneal therapy for ovarian cancer.
    Markman M
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):99-104. PubMed ID: 7678757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.